Erschienen in:
01.08.2010 | Hepatobiliary Tumors
Sequenced Chemotherapy and Surgery for Potentially Resectable Colorectal Liver Metastases: A Debate Over Goals of Research and an Approach While the Jury Remains Out
verfasst von:
Jean-Nicolas Vauthey, MD, Bernard Nordlinger, MD, Scott Kopetz, MD, Graeme Poston, MD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 8/2010
Einloggen, um Zugang zu erhalten
Excerpt
The combination of hepatic resection and chemotherapy is increasingly accepted as an effective treatment for patients with hepatic colorectal metastases with surgical series reporting 5-year survival rates in excess of 50%
1‐
3 However, controversy remains regarding the surgery-chemotherapy sequence and the type of regimens to be used in combination with surgery. Further studies can go in 1 of 2 directions: either simplification of the treatment approach (comparison between preoperative versus postoperative chemotherapy) with the goal of reducing complications or intensification of treatment (comparison of perioperative chemotherapy regimens combining cytotoxic chemotherapy and biologic therapy) with the hope of improving survival.
4 The main debate now is which question is most worthy of an answer and what do we do while the jury is out? …